Hygieia and TempraMed Announce Partnership

Livonia, Michigan, USA and Tel Aviv, Israel – Hygieia, a digital health company for insulin therapy announces a new partnership with TempraMed, a manufacturer of advanced temperature-based insulin storage solutions. This relationship brings the innovative technologies of both companies to a much broader audience, helping more people simplify and effectively manage their diabetes care. Hygieia’s…

Hygieia welcomes Heineman as Vice President of Business Development

Heineman brings over 30 years of expertise in strategic leadership, operations, and business development in the biopharmaceutical and medical device industries. She is an internationally known member of the diabetes community with a track record of opening new markets for diabetes technology.

Hygieia Extends Series B Round to $22 Million with Participation from Strategic Investors

Livonia, Mich., May 2, 2023 – Hygieia, a digital therapeutics company for insulin therapy, is extending its Series B funding round to $22 million with a lead investment from Firstime Ventures and additional investment from two strategic partners.   Hygieia is the maker of d-Nav®, the only FDA-cleared technology to autonomously adjust insulin dose recommendations to…

Hygieia Expands to Arizona, as Endocrinology Associates, PA, Joins d-Nav® Insulin Management Clinical Partnership Program

Partnership model gives physicians better tools for insulin therapy and offers new reimbursement opportunities Livonia, Michigan, Jan. 10, 2023 — Hygieia, a provider of digital therapeutics for insulin management, has added Endocrinology Associates, PA, in Scottsdale and Chandler, AZ, as a clinical partner. This makes Hygieia’s d-Nav® autonomous insulin therapy service available to patients with type…

Hygieia adds to team, continues rapid, national expansion of its d-Nav® Insulin Management Program

Demand grows for d-Nav Technology, the first FDA-cleared app to autonomously adjust insulin doses Livonia, Michigan, Dec. 13, 2022 — Hygieia, a digital therapeutics company, has relocated and expanded its headquarters to accommodate additional staff as it continues significant growth and pursues partnerships with endocrinology practices across the United States. Hygieia’s expansion is in response to increased…

Hygieia adds clinical partners in New York and North Carolina to its
d-Nav® Insulin Management Program

Partnership model increases doctors’ ability to coordinate patients’ insulin therapy andoffers new reimbursement opportunities Livonia, Mich., Sept. 12, 2022 — Hygieia, a provider of digital therapeutics for insulin management, has added Endocrine Associates of West Village P.C. in Manhattan and Long Island City, NY, and Physicians East in Greenville, NC, as clinical partners. The partnerships are…


Discover the latest insights and views about type 2 diabetes.


Explore d-Nav studies, peer reviewed and white papers.


Reinheimer PR & Marketing